Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › H2020

SiMBiT · Single molecule bio-electronic smart system array for clinical testing

H2020Status: CLOSED1 January 201931 December 2022EU funding €3,020,639Call H2020-ICT-2018-20

Digitizing biomarkers analysis by quantifying them at the single-molecule level is the new frontier for advancing the science of precision health. The SiMBiT project will develop a bio-electronic smart system leveraging on an existing lab-based proof-of-concept that can perform single-molecule detection of both proteins and DNA bio-markers. Specifically, the SiMBiT activities will develop the lab-based device into a cost-effective portable multiplexing array prototype that integrates, with a modular approach, novel materials and standard components/interfaces. The SiMBiT platform exhibits enhanced sensing capabilities: specificity towards both genomic and protein markers along with single-molecule detection limits and time-to-results within two hours. This makes the SiMBiT prototype the world best performing bio-electronic sensing system ever. SiMBiT will reach these ambitious goals with a multidisciplinary research effort involving device-physicists, analytical-chemists, bio-chemists, clinicians, electronic- and system-engineers. The platform is also single-use and cost-effective and can work in low-resource settings. The SiMBiT field-effect sensing system will be fabricated by means of future mass-manufacturable, large-area compatible, scalable techniques such as printing and other direct-writing processes. 3D printing of a module is also foreseen. The SiMBiT prototype will demonstrate, for first time, a matrix of up to 96 bio-electronic sensors and a Si IC chip for the processing of all data coming from the matrix, multiplexing single-molecule detection. As the Si IC pins are limited the chip area is reduced and its cost minimized, enabling a single-use assay plate. SiMBiT will apply the multiplexing single molecule technology to the early detection of human pancreatic neoplasms in a well-defined clinical context, performing simultaneous analysis of genomic and protein markers with a minimal sample volume, reduced costs and reduced time-to-results.

Consortium · 10 organisations

coordinator

CONSORZIO INTERUNIVERSITARIO PERLO SVILUPPO DEI SISTEMI A GRANDE INTERFASE

IT · €390,750

participant

HEINRICH-HEINE-UNIVERSITAET DUESSELDORF

DE · €415,765

participant

FLEXENABLE TECHNOLOGY LIMITED

UK · €53,312

participant

FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA

IT · €352,500

participant

FLEXENABLE LIMITED

UK · €302,092

participant

MASMEC SPA

IT · €262,500

participant

IN EXTENSO INNOVATION CROISSANCE

FR · €112,500

participant

ABO AKADEMI

FI · €350,000

participant

TECHNISCHE UNIVERSITEIT EINDHOVEN

NL · €389,999

participant

UNIVERSITA DEGLI STUDI DI BRESCIA

IT · €391,221

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.